Home Equity Loan Rates Hold Near 2026 Lows as Homeowners Delay Renovations Amid Geopolitical Uncertainty Cigna CI Considered for Dividend Growth A ThreeYear Outlook Scott Bessent Anticipates Substantial Disinflation as Kevin Warsh Takes the Helm at the Federal Reserve MACOM Technology Solutions MTSI Highlights Record Q1 Performance in Aristotle Capital Investor Letter Steel Stocks Surge as Government Extends Minimum Import Price on 66 Steel Products BlockCon Punta Cana Web3 iGaming and Finance Summit Explores Industry Convergence BSAC Q1 2026 Earnings Earnings Beat Estimates as Net Income Rises Stock Slightly Down Perspective Therapeutics Inc CATX Q1 2026 Earnings EPS Beat by 17 as PreRevenue Biotech Advances Radiopharmaceutical Pipeline STZ Q1 2026 Earnings EPS Surprise Beats Estimates Despite Flat Revenue Disclosure POET Q1 2026 Earnings EPS Misses Estimates as Company Continues PreRevenue Development HEI Q1 2026 Earnings EPS Beats Estimates Shares Rise 26 PhenixFIN Corporation PFX Q1 2026 Earnings Strong EPS Beat Driven by Investment Portfolio Stock Remains Flat National Healthcare Properties Preferred Stock NHPAP Edges Lower in Quiet Trading BayCom Corp BCML Edges Higher Amid Quiet Trading Holds Above Key Support MITP Edges Lower Amid Low Volumes as FixedIncome Markets Seek Direction Filana Therapeutics FLNA Posts Modest Gains Amid Broader Biotech Resilience Shoe Carnival SCVL Holds Steady Near Key Support with Fractional Advance UTI Q1 2026 Earnings EPS Misses Estimates but Stock Climbs on Positive Indicators KW Q1 2026 Earnings Significant EPS Beat Driven by Operational Strength MAPS Q1 2026 Earnings EPS Miss Weighs on Shares Despite Narrow Profit VAC Q1 2026 Earnings Earnings Miss Estimates Despite Stable Share Price BTCS Q1 2026 Earnings EPS Misses Estimates as DevelopmentStage Company Faces Headwinds CMTV Q4 2025 Earnings Strong EPS Performance Amid Challenging Rate Environment Frankfurt Airports New Sky Line Train Faces Technical Disruption Shortly After Launch ADXN Q1 2024 Earnings EPS Reported at 1227 No Revenue as DevelopmentStage Biotech Continues Valley National Bancorp Preferred Stock VLYPN Edges Higher as Yield Appeal Holds